NYSE:CLB Core Laboratories (CLB) Stock Forecast, Price & News $23.46 -0.55 (-2.29%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$23.30▼$24.3150-Day Range$23.46▼$27.4252-Week Range$13.48▼$27.94Volume206,054 shsAverage Volume423,168 shsMarket Capitalization$1.10 billionP/E Ratio28.27Dividend Yield0.17%Price Target$21.88 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Core Laboratories MarketRank™ ForecastAnalyst RatingSell1.33 Rating ScoreUpside/Downside6.8% Downside$21.88 Price TargetShort InterestBearish12.05% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth44.07%From $0.59 to $0.85 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.90 out of 5 starsOils/Energy Sector184th out of 238 stocksOil & Gas Field Services, Not Elsewhere Classified Industry15th out of 18 stocks 0.7 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Sell. The company's average rating score is 1.33, and is based on no buy ratings, 1 hold rating, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.88, Core Laboratories has a forecasted downside of 6.8% from its current price of $23.46.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted12.05% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 10.9, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently decreased by 19.13%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.17%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 4.82%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.71% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLB. Previous Next 2.3 News and Social Media Coverage News SentimentCore Laboratories has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 1 news article for Core Laboratories this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.60% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 44.07% in the coming year, from $0.59 to $0.85 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 28.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.06.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 28.27, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 13.99.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 0.83. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 5.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Core Laboratories (NYSE:CLB) StockCore Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, hydrogen storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. The company was founded in 1936 and is based in Houston, Texas.Read More CLB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLB Stock News HeadlinesSeptember 19, 2023 | msn.comCitigroup Maintains Core Laboratories (CLB) Sell RecommendationSeptember 19, 2023 | americanbankingnews.comCitigroup Trims Core Laboratories (NYSE:CLB) Target Price to $20.00September 27, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 19, 2023 | americanbankingnews.comCore Laboratories Inc. (NYSE:CLB) Given Consensus Rating of "Strong Sell" by BrokeragesSeptember 12, 2023 | finance.yahoo.comThe Zacks Analyst Blog Highlights BP, Core Laboratories and Global PartnersSeptember 7, 2023 | finance.yahoo.comZacks Industry Outlook Highlights Schlumberger, Halliburton, Core Laboratories and Solaris Oilfield InfrastructureSeptember 7, 2023 | finance.yahoo.comTap the Crude Rally With These Three Promising Energy StocksSeptember 7, 2023 | finance.yahoo.comEquinor (EQNR) Acquires Poland Wind Farm From Helios GroupSeptember 27, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.September 6, 2023 | finance.yahoo.comEnbridge (ENB) Signs Deal to Buy Gas Utilities From DominionSeptember 6, 2023 | finance.yahoo.comStrength Seen in Liberty Oilfield Services (LBRT): Can Its 7.6% Jump Turn into More Strength?August 25, 2023 | finance.yahoo.comCore Laboratories (CLB) Down 4% Since Last Earnings Report: Can It Rebound?August 17, 2023 | fool.comCore Laboratories (NYSE: CLB)August 3, 2023 | msn.comCore Laboratories (CLB) Declares $0.01 DividendAugust 1, 2023 | nasdaq.comPiper Sandler Maintains Core Laboratories (CLB) Neutral RecommendationJuly 31, 2023 | markets.businessinsider.comCore Laboratories (CLB) Receives a Hold from Piper SandlerJuly 30, 2023 | finance.yahoo.comCore Laboratories Second Quarter 2023 Earnings: EPS Beats Expectations, Revenues LagJuly 28, 2023 | finance.yahoo.comCore Laboratories (CLB) Q2 2023 Earnings Call TranscriptJuly 26, 2023 | finance.yahoo.comCore Laboratories (CLB) Tops Q2 Earnings EstimatesJuly 26, 2023 | finance.yahoo.comCompared to Estimates, Core Laboratories (CLB) Q2 Earnings: A Look at Key MetricsJuly 25, 2023 | benzinga.comEarnings Preview: Core LaboratoriesJuly 24, 2023 | finance.yahoo.comIndividual investors account for 54% of Core Laboratories Inc.'s (NYSE:CLB) ownership, while institutions account for 46%July 11, 2023 | finance.yahoo.comRetired Food Scientist Lists Coastal California Home for $42.5 MillionJuly 10, 2023 | finance.yahoo.comCore Laboratories Inc.'s (NYSE:CLB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?June 30, 2023 | msn.comCore Labs slashed to Sell at Citi on North America completion weaknessJune 30, 2023 | markets.businessinsider.com4 Analysts Have This to Say About Core LaboratoriesJune 29, 2023 | money.usnews.comCore Laboratories IncSee More Headlines Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Company Calendar Last Earnings7/26/2023Ex-Dividend for 8/28 Dividend8/04/2023Dividend Payable8/28/2023Today9/27/2023Next Earnings (Estimated)10/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Forecast$21.88 High Stock Price Forecast$25.00 Low Stock Price Forecast$20.00 Forecasted Upside/Downside-6.8%Consensus RatingSell Rating Score (0-4)1.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.83 Trailing P/E Ratio28.27 Forward P/E Ratio39.76 P/E Growth0.83Net Income$19.45 million Net Margins7.75% Pretax Margin8.39% Return on Equity16.83% Return on Assets5.69% Debt Debt-to-Equity Ratio0.83 Current Ratio2.45 Quick Ratio1.71 Sales & Book Value Annual Sales$489.73 million Price / Sales2.24 Cash Flow$0.92 per share Price / Cash Flow25.63 Book Value$4.07 per share Price / Book5.76Miscellaneous Outstanding Shares46,680,000Free Float46,400,000Market Cap$1.10 billion OptionableOptionable Beta2.68 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Lawrence V. Bruno (Age 63)Chairman, CEO, Pres & COO Comp: $1.53MMr. Christopher Scott Hill (Age 53)Sr. VP & CFO Comp: $682.02kMs. Gwendolyn Y. Gresham M.B.A. (Age 55)Sr. VP of Corp. Devel. & Investor Relations Comp: $564.28kMr. Mark Damian Tattoli (Age 51)Sr. VP, Sec. & Gen. Counsel Comp: $562.44kMr. Kevin G. Daniels (Age 59)Chief Accounting Officer, Treasurer & VP Mr. Jacobus Schouten (Age 68)Managing Director J. Donald Dumas Jr.Sr. VP of Production Enhancement & Bus. Devel.More ExecutivesKey CompetitorsProPetroNYSE:PUMPProFracNASDAQ:PFHCHelix Energy Solutions GroupNYSE:HLXProFracNASDAQ:ACDCRanger Energy ServicesNYSE:RNGRView All CompetitorsInstitutional OwnershipPortside Wealth Group LLCBought 58,380 shares on 9/1/2023Ownership: 0.125%Osaic Holdings Inc.Bought 14,858 shares on 8/21/2023Ownership: 0.143%California State Teachers Retirement SystemBought 15,902 shares on 8/21/2023Ownership: 0.121%Teachers Retirement System of The State of KentuckyBought 813 shares on 8/21/2023Ownership: 0.033%Nuveen Asset Management LLCBought 135,437 shares on 8/16/2023Ownership: 0.290%View All Institutional Transactions CLB Stock - Frequently Asked Questions Should I buy or sell Core Laboratories stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "sell" CLB shares. View CLB analyst ratings or view top-rated stocks. What is Core Laboratories' stock price forecast for 2023? 3 equities research analysts have issued 12-month price objectives for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $25.00. On average, they anticipate the company's stock price to reach $21.88 in the next year. This suggests that the stock has a possible downside of 6.8%. View analysts price targets for CLB or view top-rated stocks among Wall Street analysts. How have CLB shares performed in 2023? Core Laboratories' stock was trading at $20.27 on January 1st, 2023. Since then, CLB shares have increased by 15.7% and is now trading at $23.46. View the best growth stocks for 2023 here. Are investors shorting Core Laboratories? Core Laboratories saw a drop in short interest in August. As of August 31st, there was short interest totaling 5,580,000 shares, a drop of 19.1% from the August 15th total of 6,900,000 shares. Based on an average trading volume of 512,400 shares, the short-interest ratio is currently 10.9 days. Approximately 12.1% of the company's stock are short sold. View Core Laboratories' Short Interest. When is Core Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023. View our CLB earnings forecast. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) issued its quarterly earnings results on Wednesday, July, 26th. The oil and gas company reported $0.23 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The oil and gas company earned $127.88 million during the quarter, compared to analyst estimates of $132.20 million. Core Laboratories had a net margin of 7.75% and a trailing twelve-month return on equity of 16.83%. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories announced a quarterly dividend on Wednesday, July 26th. Investors of record on Monday, August 7th will be given a dividend of $0.01 per share on Monday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.17%. The ex-dividend date is Friday, August 4th. Read our dividend analysis for CLB. What ETFs hold Core Laboratories' stock? ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Alger Weatherbie Enduring Growth ETF (AWEG), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ) and VanEck Oil Services ETF (OIH).Direxion Daily Oil Services Bull 2X Shares (ONG). Is Core Laboratories a good dividend stock? Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.17%. The dividend payout ratio is 4.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.71% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CLB. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories updated its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $0.21-$0.25 for the period, compared to the consensus earnings per share estimate of $0.23. The company issued revenue guidance of $128.00 million-$132.00 million, compared to the consensus revenue estimate of $135.99 million. What is David M. Demshur's approval rating as Core Laboratories' CEO? 60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD). What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Ariel Investments LLC (20.63%), BlackRock Inc. (16.98%), Earnest Partners LLC (8.22%), Boston Trust Walden Corp (4.71%), State Street Corp (3.96%) and Congress Asset Management Co. MA (2.08%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $23.46. How much money does Core Laboratories make? Core Laboratories (NYSE:CLB) has a market capitalization of $1.10 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.83 on an earnings per share basis. How many employees does Core Laboratories have? The company employs 3,600 workers across the globe. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (713) 328-2673 or via email at investor.relations@corelab.com. This page (NYSE:CLB) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.